Stock VERO VENUS CONCEPT INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Venus Concept Inc.

Equities

VERO

US92332W2044

Delayed Nasdaq
Other stock markets
 09:33:49 2024-04-19 am EDT 		5-day change 1st Jan Change
0.8672 USD +3.24% Intraday chart for Venus Concept Inc. +27.98% -26.51%
Apr. 08 Venus Concept Inc. Announces Israeli Regulatory Approval for Venus Bliss MAX CI
Apr. 01 Transcript : Venus Concept Inc., Q4 2023 Earnings Call, Apr 01, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
AQ
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
AQ
Venus Concept Inc. Announces Israeli Regulatory Approval for Venus Bliss MAX
CI
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
AQ
Transcript : Venus Concept Inc., Q4 2023 Earnings Call, Apr 01, 2024
Venus Concept Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Venus Concept: Q4 Earnings Snapshot
AQ
Venus Concept Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Earnings Flash (VERO) VENUS CONCEPT Posts Q4 Revenue $18.1M
MT
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
AQ
Venus Concept Inc. Provides Earning Guidance for the Three Months Ended March 31, 2024
CI
Venus Concept Continues Listing on Nasdaq, Gets May Deadline to Meet Equity Requirement
MT
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
AQ
Certain Options of Venus Concept Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.
CI
Venus Concept Launches “NEXThetics” Program
AQ
Venus Concept Inc. announced that it has received CAD 1.095782 million in funding
CI
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
AQ
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
AQ
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
AQ
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VERO Stock
  4. News Venus Concept Inc.